Ratio of Endogenous Secretory Receptor for Advanced Glycation End Products to Pentosidine Predicts Fractures in Men | Zendy

Junko Tamaki | Zendy; Katsuyasu Kouda | Zendy; Yuki Fujita | Zendy; Masayuki Iki | Zendy; A. Yura | Zendy; Masakazu Miura | Zendy; Yuho Sato | Zendy; Nozomi Okamoto | Zendy; Norio Kurumatani | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Ratio of Endogenous Secretory Receptor for Advanced Glycation End Products to Pentosidine Predicts Fractures in Men

Author(s) -

Junko Tamaki,

Katsuyasu Kouda,

Yuki Fujita,

Masayuki Iki,

A. Yura,

Masakazu Miura,

Yuho Sato,

Nozomi Okamoto,

Norio Kurumatani

Publication year - 2017

Publication title -

the journal of clinical endocrinology and metabolism

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.206

H-Index - 353

eISSN - 1945-7197

pISSN - 0021-972X

DOI - 10.1210/jc.2017-00929

Subject(s) - medicine , pentosidine , hazard ratio , glycated hemoglobin , confidence interval , osteoporosis , femoral neck , glycation , bone mineral , cohort , endocrinology , advanced glycation end product , urology , gastroenterology , diabetes mellitus , receptor , type 2 diabetes

Although the endogenous secretory receptor for advanced glycation end products (esRAGE) has been associated with reduced activity of pentosidine (PEN), the association between PEN, esRAGE, and fracture is poorly understood.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research